Confronting clinical tradition: ipsilateral arm use after breast cancer surgery in Japan
- 3 November 2025
- journal article
- research article
- Published by Springer Nature in Journal of Anesthesia
- Vol. 40 (3) , 416-421
Abstract
The long-standing practice of prohibiting ipsilateral arm use for intravenous access, blood draws, or blood pressure monitoring after breast cancer surgery has persisted in many countries and remains common in some Japanese institutions, often based on routine signage and overly simplified education. While historically justified in the era of Halsted’s radical mastectomy owing to high postoperative lymphedema rates, today’s surgical landscape, with the increasing use of breast-conserving surgery and sentinel lymph node biopsy (SLNB), has seen a marked decline in clinically significant arm swelling. Recent large retrospective studies and society statements (Society for Ambulatory Anesthesia, American Society of Breast Surgeons, and Australian and New Zealand College of Anaesthetists) support risk-based, individualized assessments rather than blanket exclusion. This article examines the cultural, educational, and systemic factors that maintain outdated restrictions and presents a symptom-guided risk stratification framework. Asymptomatic patients 1 year after SLNB or 3 years after axillary lymph node dissection/regional lymph node radiation are at low risk for access-related complications. This article explores the unintended harm of rigid policies, including compromised access, delay in care, and patient distress, and proposes strategies for institution-level policy revision and patient education. Shifting from prohibition to personalization aligns clinical practice with modern evidence, promotes patient autonomy, and prevents the perpetuation of outdated norms. Graphical abstractKeywords
This publication has 13 references indexed in Scilit:
- Development and validation of a predictive nomogram for postoperative upper limb lymphedema in breast cancer patients: a retrospective cohort studyScientific Reports, 2025
- Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer PatientsAnnals of Surgery, 2022
- Ipsilateral Intravenous Catheter Placement in Breast Cancer Surgery PatientsAnesthesia & Analgesia, 2021
- Breast cancer-related lymphedema: risk factors, precautionary measures, and treatmentsGland Surgery, 2018
- Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic OptionsAnnals of Surgical Oncology, 2017
- Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS PanelAnnals of Surgical Oncology, 2017
- Impact of Ipsilateral Blood Draws, Injections, Blood Pressure Measurements, and Air Travel on the Risk of Lymphedema for Patients Treated for Breast CancerJournal of Clinical Oncology, 2016
- Breast cancer-related lymphoedema and venepuncture: a review and evidence-based recommendationsBreast Cancer Research and Treatment, 2015
- Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysisThe Lancet Oncology, 2013
- Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective MeasurementsJournal of Clinical Oncology, 2008